RevenueNet IncomeP/EP/SEBITDividendStocksMarket capitalizationDebtLiabilitiesEquityAAQSEmployeesROEROAROCE
Novozymes A/S Stock

Novozymes A/S Revenue 2024

Novozymes A/S Revenue

3.98 B DKK

Ticker

NSIS B.CO

ISIN

DK0060336014

WKN

A1JP9Y

In 2024, Novozymes A/S's sales reached 3.98 B DKK, a 65.94% difference from the 2.4 B DKK sales recorded in the previous year.

The Novozymes A/S Revenue history

YEARREVENUE (undefined DKK)GROSS MARGIN (%)
2029e40.873,19
2028e38.763,36
2027e35.973,63
2026e4.5528,69
2025e4.2630,65
2024e3.9832,73
20232.454,32
20222.3554,56
20212.0157,78
202014.0156,04
201914.3755,57
201814.3957,69
201714.5358,00
201614.1457,74
20151458,44

Novozymes A/S Revenue, EBIT, Net Income

  • 3 years

  • 5 years

  • 10 years

  • 25 Years

  • Max

Revenue
EBIT
Net Income
Details

Revenue, EBIT and Profit

ⓘ

Understanding Revenue, EBIT, and Income

Gain insights into Novozymes A/S, a comprehensive overview of its financial performance can be obtained by analyzing the Revenue, EBIT, and Income chart. Revenue represents the total income generated by Novozymes A/S from its primary operations, showcasing the company’s ability to attract and retain clients. EBIT, or Earnings Before Interest and Taxes, indicates the company’s operational profitability, free from the influence of tax and interest expenses. The Income section reflects Novozymes A/S’s net earnings, an ultimate measure of its financial health and profitability.

Yearly Analysis and Comparisons

Observe the yearly bars to understand the annual performance and growth of Novozymes A/S. Compare the Revenue, EBIT, and Income to evaluate the company’s efficiency and profitability. A higher EBIT compared to the previous year suggests an improvement in operational efficiency. Likewise, an increase in Income indicates enhanced overall profitability. Analyzing the year-to-year comparison assists investors in understanding the company’s growth trajectory and operational efficiency.

Utilizing Expectations for Investment

The expected values for the forthcoming years offer investors a glimpse into Novozymes A/S’s anticipated financial performance. Analyzing these projections alongside historical data aids in making informed investment decisions. Investors can gauge the potential risks and returns, aligning their investment strategies accordingly to optimize profitability and mitigate risks.

Investment Insights

Leveraging the comparison between Revenue and EBIT helps in assessing Novozymes A/S’s operational efficiency, while the Revenue and Income comparison reveals the net profitability after accounting for all expenses. Investors can derive valuable insights by meticulously analyzing these financial parameters, laying the foundation for strategic investment decisions aimed at capitalizing on Novozymes A/S’s growth potential.

Novozymes A/S Revenue, EBIT and net profit per share

DateNovozymes A/S RevenueNovozymes A/S EBITNovozymes A/S Net Income
2029e40.87 B DKK0 DKK8.74 B DKK
2028e38.76 B DKK11.95 B DKK7.88 B DKK
2027e35.97 B DKK10.92 B DKK7.27 B DKK
2026e4.55 B DKK1.24 B DKK838.32 M DKK
2025e4.26 B DKK1.13 B DKK744.76 M DKK
2024e3.98 B DKK955.74 M DKK616.38 M DKK
20232.4 B DKK598.77 M DKK405.62 M DKK
20222.35 B DKK597.7 M DKK493.07 M DKK
20212.01 B DKK526.74 M DKK421.98 M DKK
202014.01 B DKK3.61 B DKK2.83 B DKK
201914.37 B DKK3.66 B DKK3.15 B DKK
201814.39 B DKK4.15 B DKK3.23 B DKK
201714.53 B DKK4.14 B DKK3.12 B DKK
201614.14 B DKK3.99 B DKK3.05 B DKK
201514 B DKK3.94 B DKK2.82 B DKK

Novozymes A/S stock margins

The Novozymes A/S margin analysis displays the gross margin, EBIT margin, as well as the profit margin of Novozymes A/S. The EBIT margin (EBIT/sales) indicates the percentage of sales that remains as operating profit. The profit margin shows the percentage of sales that remains for Novozymes A/S.

  • 3 years

  • 5 years

  • 10 years

  • 25 Years

  • Max

Gross margin
EBIT margin
Profit margin
Details

Margin

ⓘ

Understanding Gross Margin

The gross margin, expressed as a percentage, delineates the gross profit made from the Novozymes A/S's sales revenue. A higher gross margin percentage indicates that the Novozymes A/S retains more revenue after accounting for the costs of goods sold. Investors use this metric to gauge financial health and operational efficiency, as well as to compare it with competitors and industry averages.

EBIT Margin Analysis

EBIT margin represents the Novozymes A/S's earnings before interest and taxes. Analyzing the EBIT margin over different years provides insights into the operational profitability and efficiency, excluding the effects of financial leverage and tax structure. A growing EBIT margin over the years signifies improving operational performance.

Revenue Margin Insights

The revenue margin demonstrates the Novozymes A/S's total revenue generated. When comparing the revenue margin year over year, investors can gauge the Novozymes A/S's growth and market expansion. It is essential to compare the revenue margin with the gross and EBIT margins to understand the cost and profit structures better.

Interpreting Expectations

The expected values for gross, EBIT, and revenue margins provide future financial outlook of the Novozymes A/S. Investors should compare these expectations with historical data to understand potential growth and risk factors. It is crucial to consider the underlying assumptions and methodologies used in projecting these expected values to make informed investment decisions.

Comparative Analysis

Comparing the gross, EBIT, and revenue margins, both yearly and over multiple years, enables investors to perform a comprehensive analysis of the Novozymes A/S's financial health and growth prospects. Evaluating the trends and patterns in these margins helps in identifying strengths, weaknesses, and potential investment opportunities.

Novozymes A/S Margin History

Novozymes A/S Gross marginNovozymes A/S Profit marginNovozymes A/S EBIT marginNovozymes A/S Profit margin
2029e54.32 %0 %21.38 %
2028e54.32 %30.84 %20.32 %
2027e54.32 %30.35 %20.21 %
2026e54.32 %27.25 %18.44 %
2025e54.32 %26.65 %17.5 %
2024e54.32 %23.99 %15.47 %
202354.32 %24.94 %16.89 %
202254.56 %25.39 %20.94 %
202157.78 %26.27 %21.04 %
202056.04 %25.76 %20.16 %
201955.57 %25.49 %21.94 %
201857.69 %28.82 %22.42 %
201758 %28.49 %21.46 %
201657.74 %28.19 %21.57 %
201558.44 %28.12 %20.16 %

Novozymes A/S Aktienanalyse

What does Novozymes A/S do?

Novozymes A/S is a leading company in the field of biocatalysis and microbial solutions. It was founded in Denmark in 1925 under the name Nordisk Insulinlaboratorium. In 2000, the company was renamed Novozymes A/S and became part of the globally operating Novo Group. Novozymes' business model is to optimize the use of biocatalysts, enzymes, and microorganisms to offer sustainable solutions for various industries. Biocatalysts are biological molecules that accelerate or enable chemical reactions. The company works closely with customers in agriculture, household, food and beverage, laundry and cleaning products, animal feed, bioenergy, and biopharmaceutical industries. Novozymes' offerings include various divisions. The largest is the enzymes division, which produces enzymes for various industries. Novozymes' enzymes are used in the food and beverage industry, pulp and paper industry, and bioenergy, among others. The microbial solutions division offers various microorganisms that can be used in the production of biogas, animal feed, or odor removal. Novozymes also has a bioagriculture division that develops solutions for sustainable agriculture. This includes disease- and pest-resistant bioseeds, as well as enhanced soil and plant care. The company also has a biopharmaceutical division that focuses on producing enzymes for disease treatment. An important goal of Novozymes is to promote sustainability and environmental protection. The company advocates for the use of renewable resources and energy-efficient processes. This is also reflected in their products, which contribute to optimizing agricultural processes and reducing greenhouse gas emissions, for example. One example of a Novozymes product is NovoGro, a biofertilizer for sustainable agriculture. NovoGro enhances nutrient uptake in plants and contributes to healthy soils. Another product is an enzyme blend called Novozyme 188, which is used in beer production to improve filtration. In summary, Novozymes A/S is a company specializing in biocatalysis and microbial solutions. The company works closely with customers from various industries to offer sustainable solutions and promote environmental protection. Novozymes has different divisions and offers solutions such as enzymes and microorganisms that can be used in the food and beverage industry, pulp and paper industry, bioenergy, biopharmaceuticals, and many other areas. With its commitment to sustainability and environmental protection, Novozymes contributes to shaping a better future. Novozymes A/S ist eines der beliebtesten Unternehmen auf Eulerpool.com.

Revenue Details

Understanding Novozymes A/S's Sales Figures

The sales figures of Novozymes A/S originate from the total revenue accrued from goods sold or services provided during a specific time period. These numbers are a direct reflection of the company’s ability to translate its products or services into revenue, indicating the demand and market presence.

Year-to-Year Comparison

Analyzing Novozymes A/S’s yearly sales data offers insights into the company’s growth and stability. An increase in sales suggests a growing demand for its offerings, efficient marketing, or expansion into new markets. Conversely, a decline might indicate market saturation, increased competition, or less effective strategies.

Impact on Investments

Investors often scrutinize Novozymes A/S's sales data to evaluate its financial health and growth prospects. Consistent sales growth can be a promising indicator of the company’s profitability and potential return on investment, influencing stock prices and investor confidence.

Interpreting Sales Fluctuations

Increases in Novozymes A/S’s sales indicate market growth, innovation, or effective marketing, often leading to a surge in stock prices. A decline, however, can signal challenges requiring strategic adjustments to enhance market share and profitability.

Frequently Asked Questions about Novozymes A/S stock

How much revenue did Novozymes A/S generate this year?

Novozymes A/S has achieved a revenue of 3.98 B DKK this year.

How much was the turnover of the company Novozymes A/S compared to the previous year?

The revenue of Novozymes A/S has increased by 65.94% increased compared to the previous year.

What does revenue mean for investors?

The revenue of a company is an important indicator of its financial performance and attractiveness for investors.

Which factors influence the revenue of Novozymes A/S?

The revenue of Novozymes A/S is influenced by various factors, including the demand for its products and services, market conditions, and prices.

How is the revenue of Novozymes A/S measured?

Revenue is typically measured in units referring to the sale of goods and services provided by the company.

How does an increase in sales affect investments?

An increase in revenue can prompt investors to invest more money in the company as it serves as a positive signal for its financial performance and growth prospects.

What are the possible risks associated with a declining revenue?

A decline in revenue can prompt investors to invest less money in the company, as it is a negative signal for its financial performance and growth prospects.

Why is the sales revenue of Novozymes A/S so important for investors?

The revenue of Novozymes A/S is an important indicator of financial performance and attractiveness for investors.

What strategic measures can a company take to increase revenue?

A company can take various strategic measures to increase revenue, including developing new products and services, introducing new pricing models, and expanding into new markets.

How much dividend does Novozymes A/S pay?

Over the past 12 months, Novozymes A/S paid a dividend of 10.2 DKK . This corresponds to a dividend yield of about 2.41 %. For the coming 12 months, Novozymes A/S is expected to pay a dividend of 5.26 DKK.

What is the dividend yield of Novozymes A/S?

The current dividend yield of Novozymes A/S is 2.41 %.

When does Novozymes A/S pay dividends?

Novozymes A/S pays a quarterly dividend. This is distributed in the months of April, November, June, September.

How secure is the dividend of Novozymes A/S?

Novozymes A/S paid dividends every year for the past 15 years.

What is the dividend of Novozymes A/S?

For the upcoming 12 months, dividends amounting to 5.26 DKK are expected. This corresponds to a dividend yield of 1.24 %.

In which sector is Novozymes A/S located?

Novozymes A/S is assigned to the 'Commodities' sector.

Wann musste ich die Aktien von Novozymes A/S kaufen, um die vorherige Dividende zu erhalten?

To receive the latest dividend of Novozymes A/S from 9/3/2024 amounting to 2 DKK, you needed to have the stock in your portfolio before the ex-date on 8/30/2024.

When did Novozymes A/S pay the last dividend?

The last dividend was paid out on 9/3/2024.

What was the dividend of Novozymes A/S in the year 2023?

In the year 2023, Novozymes A/S distributed 5.5 DKK as dividends.

In which currency does Novozymes A/S pay out the dividend?

The dividends of Novozymes A/S are distributed in DKK.

Stock savings plans offer an attractive way for investors to build wealth over the long term. One of the main advantages is the so-called cost-average effect: by regularly investing a fixed amount in stocks or stock funds, you automatically buy more shares when prices are low, and fewer when they are high. This can lead to a more favorable average price per share over time. In addition, stock savings plans allow small investors access to expensive stocks, as they can participate with small amounts. Regular investment also promotes a disciplined investment strategy and helps to avoid emotional decisions, such as impulsive buying or selling. Furthermore, investors benefit from the potential appreciation of the stocks as well as from dividend distributions, which can be reinvested, enhancing the compounding effect and thus the growth of the invested capital.

The Novozymes A/S stock can be added to a savings plan with the following providers: Trade Republic

Andere Kennzahlen von Novozymes A/S

Our stock analysis for Novozymes A/S Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Novozymes A/S Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.